What History Teaches Us About Drug Repurposing in Lung Cancer The scientific community has explored the potential of repurposing existing medications for lung cancer before, and the history of those efforts offers important perspective
The dose is then gradually increased to 0.5 mg weekly for another four weeks, followed by subsequent increases to 1.0 mg, and 1.7 mg, and ultimately reaching the maintenance dose of 2.4 mg per week after a 16-week dose escalation period [17]
2017 Apr 26;8(2):15362
-10,
Peripheral Nerve Regeneration: The Synergistic Potential of ARA-290 and BPC-157 in Neuropathic Research Discover how combining ARA-290 and BPC-157 can accelerate peripheral nerve regeneration
[DOI] [PMC free article] [PubMed] [Google Scholar] 39.Jones B., Burade V., Akalestou E., Manchanda Y., Ramchunder Z., Carrat G., Nguyen-Tu M.S., Marchetti P., Piemonti L., Leclerc I., et al